S6E7: Next-Gen Lipid-Lowering Strategies: ANGPTL4 Inhibitor Clinical Insights
Update: 2025-08-20
Description
In this episode, Alan Brown, MD, MHA, MNLA sits down with Rebecca Juliano, PhD, MPhil, MA to discuss a first-in-human study of an investigational ANGPTL4 inhibitory antibody. The conversation explores how this novel therapeutic approach safely and effectively reduces plasma triglycerides and remnant cholesterol—key drivers of residual cardiovascular risk. Listeners will gain insight into the mechanism of action, clinical significance, and potential role of ANGPTL4 inhibition in the evolving landscape of lipid management.
View this Episode on YouTube HERE
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
